A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.
about
Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesisHuman G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxisCloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5Secreted cathepsin L generates endostatin from collagen XVIIIMammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localizationRegulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytesRoles of platelet factor 4 in hematopoiesis and angiogenesisBiosynthesis and enzymatic characterization of human SKI-1/S1P and the processing of its inhibitory prosegmentVasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.Blood platelet and monocyte activations and relation to stages of liver cirrhosisAngiogenesis modulates the tumour immune response.Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin.Angiogenesis in epithelian ovarian cancer.The hemostatic system and angiogenesis in malignancy.Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells.Increased production of low molecular weight recombinant proteins in Escherichia coli.The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.Angiogenesis is an independent prognostic factor in malignant mesothelioma.Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo.The biochemistry of cancer dissemination.Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.cCXCR1 is a receptor for cIL-8 (9E3/cCAF) and its N- and C-terminal peptides and is also activated by hIL-8 (CXCL8).Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice.Role of chemokine (C-C motif) ligand 24 in spatial arrangement of the inner cell mass of the bovine embryo.Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity
P2860
Q21328694-8C10043E-CCBD-48B9-A0E6-B6B6920ED050Q22010731-C1A61C49-20AD-4553-A61B-6B78286F5F77Q24318708-053D0A3A-6F52-4061-8342-22AE0EA1555BQ24599981-D056A981-BB77-4E33-91D0-2D71B47F2E8FQ24675925-0C6EC74E-5000-4B94-AB81-4247E0469F88Q28072580-1D5B1A8E-1FC5-43CC-8D55-A1B156D71A6FQ28249954-91177176-82F2-4CC0-B6C4-9C6EB46C6F4CQ28294538-5F28C058-A5CE-4E56-A04E-D6998B67F129Q28640526-C088C52F-C588-4859-90AE-62625A442435Q33112683-7F69AACC-813D-432D-A92E-13862B2F8FA4Q33366214-7F474DE3-FE0D-4C8B-B4FE-2F79A6658512Q33630427-345DD5CB-DFDF-4D67-99E7-EF370701B9EDQ33861490-B81DDC33-BA9D-453A-BF43-97CE7B619AB1Q33889173-46D448B9-A532-4D06-B335-53FCEA0B2518Q33919078-4A1846F6-D1DE-4DD9-A8BD-CA513D2C2775Q34425462-11318ABC-9D1E-4B85-8136-95166FED8464Q35193397-7A506F4A-785D-4A12-BD30-7605D5FE7415Q35237418-292EC6CA-FB6A-4938-9607-DCE9E2EA6A31Q36280580-09670A02-2F08-4EEE-85A3-77DCD2F191F2Q36598768-B2EE59D2-88FE-44F3-B916-75F5BABCEA3FQ36643416-B7E8C0C3-B8C0-4476-9A40-605142887E4DQ37407741-B7557AB0-4FDD-4C1C-810A-FD31396DC8C2Q40705863-A300F385-6D28-41AB-BAA8-281E0F820442Q40744489-A84D89AA-4E46-426C-9523-4C3DA45CDF1CQ41547351-2CD94501-BDD6-4851-AC58-CCD61D80252DQ42099455-36B28EC2-BF5F-4502-A75E-790C04CCC8BEQ42822920-C72DF674-DC69-4644-8FFB-F81151FB6A97Q43714114-FB685A8E-B2BC-4D57-9C77-33EEEECAFB70Q45882188-FBBEABFC-868F-48BE-8B76-07F081942AEEQ53328522-B4141DB1-5523-40F8-BBFC-54F0F76A03C5Q55173831-00CC6B59-FC71-448F-B394-37C488F23634
P2860
A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@ast
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@en
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@nl
type
label
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@ast
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@en
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@nl
prefLabel
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@ast
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@en
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@nl
P2093
P2860
P356
P1476
A potent inhibitor of endothel ...... e chemokine platelet factor 4.
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.17.7799
P407
P577
1995-08-01T00:00:00Z